FARMORUBICIN 50MG INJ.
Farmorubicin - Regression in a broad spectrum of neoplastic diseases including mammary carcinoma, malignant lymphomas, soft tissue sarcomas, gastric, hepatic, pancreatic and sigma-rectum carcinomas, head and neck carcinoma, lung carcinoma, ovarian carcinoma and leukaemias.
Indications: malignant neoplasms
Indications: breast cancer, bladder cancer
Lymphoma,Multiple myeloma,Solid tumours,Acute leukaemias,Adjuvant treatment of axillary-node positive breast cancer,Local treatment of bladder carcinoma.
Enoxaparin is a low molecular weight heparin marketed as Lovenox or Clexane. It is used to prevent and treat deep vein thrombosis or pulmonary embolism, and is given as a subcutaneous injection (by a health care provider or the patient). Its use is evolving in acute coronary syndromes (ACS).
Enoxaparin is manufactured by Sanofi-Aventis and is derived from the intestinal mucosa of pigs.
Indications: Breast carcinoma, malignant lymphomas, soft tissue sarcoma, gastric, hepatic, pancreatic sigmoid; and rectum carcinomas, head and neck carcinoma, lung carcinoma, ovarian carcinoma and leukemias.